| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |